Amgen Inc. (NASDAQ: AMGN) plans resale of 2,970 shares via broker

Rhea-AI Filing Summary

Amgen Inc. has a filing covering a planned sale of up to 2,970 shares of common stock through Raymond James & Associates on or after 08/06/2026 on NASDAQ. The shares derive from cashless stock option exercises dated 04/27/2018 for 1,970 shares and 05/03/2019 for 1,000 shares. The Securities Information section also lists a related figure of 1,193,940.00 alongside the 2,970 shares.

Key Figures

Shares of common stock planned for sale: 2,970 shares Associated value figure: 1,193,940.00 Shares from 04/27/2018 cashless option exercise: 1,970 shares +2 more

5 metrics

Shares of common stock planned for sale 2,970 shares Total shares listed in the Securities Information section

Associated value figure 1,193,940.00 Figure shown alongside 2,970 shares in Securities Information

Shares from 04/27/2018 cashless option exercise 1,970 shares Securities To Be Sold entry dated 04/27/2018

Shares from 05/03/2019 cashless option exercise 1,000 shares Securities To Be Sold entry dated 05/03/2019

Planned sale date 08/06/2026 Date listed in Securities Information and Securities To Be Sold

Key Terms

Cashless Stock Option Exercise, Securities Information, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Cashless Stock Option Exercise financial

"Common | 04/27/2018 | Cashless Stock Option Exercise | Amgen Inc"

Securities Information financial

"144/A: Securities Information Common | Raymond James & Associates"

Securities To Be Sold financial

"144/A: Securities To Be Sold Common | 04/27/2018 | Cashless Stock"

Securities Sold During The Past 3 Months financial

"144/A: Securities Sold During The Past 3 Months 144/A: Remarks"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 03:17 PM Accepted by SEC EDGAR 08/06/2026 - 03:17 PM Learn about SEC filing dates

FAQ

What does the Amgen (AMGN) Form 144/A filing describe?

It describes a planned sale of 2,970 Amgen common shares through Raymond James & Associates, arising from cashless stock option exercises in 2018 and 2019, with trading noted for NASDAQ on or after 08/06/2026.

How many Amgen (AMGN) shares are planned for sale in this filing?

The filing lists a total of 2,970 common shares to be sold. These shares are broken into 1,970 shares from an option exercise on 04/27/2018 and 1,000 shares from an option exercise on 05/03/2019.

What transactions generated the Amgen (AMGN) shares to be sold?

The shares come from cashless stock option exercises on 04/27/2018 and 05/03/2019. The earlier exercise accounts for 1,970 shares, while the later exercise accounts for 1,000 shares, together totaling 2,970 shares.

Which broker is handling the planned Amgen (AMGN) share sale?

The broker listed is Raymond James & Associates, located at 880 Carillon Parkway, St. Petersburg, FL 33716. The transaction relates to Amgen common stock intended for sale on NASDAQ.

What valuation figure is associated with the Amgen (AMGN) shares in this filing?

Next to the 2,970 shares of Amgen common stock, the Securities Information section shows a figure of 1,193,940.00. This value is presented together with the share amount for the planned sale.

When is the planned sale date for the Amgen (AMGN) shares?

The entry lists 08/06/2026 in connection with the planned sale of 2,970 Amgen common shares. This date appears in both the Securities Information and Securities To Be Sold sections as the relevant sale timing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	2970	1193940.00	539000000	08/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/27/2018	Cashless Stock Option Exercise	Amgen Inc			1970	08/06/2026	Cash
Common	05/03/2019	Cashless Stock Option Exercise	Amgen Inc			1000	08/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)